These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9356333

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect.
    Rao BM, Driver I, Lauffenburger DA, Wittrup KD.
    Mol Pharmacol; 2004 Oct; 66(4):864-9. PubMed ID: 15385640
    [Abstract] [Full Text] [Related]

  • 24. Genetic instability as a basis for transformation of human lymphocytes infected with human retrovirus.
    Maruyama K, Mochizuki S, Kawamura K, Koshikawa N.
    Cancer Detect Prev; 1996 Oct; 20(2):87-93. PubMed ID: 8706044
    [Abstract] [Full Text] [Related]

  • 25. Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line.
    Higuchi M, Tsubata C, Kondo R, Yoshida S, Takahashi M, Oie M, Tanaka Y, Mahieux R, Matsuoka M, Fujii M.
    J Virol; 2007 Nov; 81(21):11900-7. PubMed ID: 17715223
    [Abstract] [Full Text] [Related]

  • 26. Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.
    Cheng J, Zhang D, Zhou C, Marasco WA.
    Leuk Res; 2004 Jan; 28(1):71-82. PubMed ID: 14630083
    [Abstract] [Full Text] [Related]

  • 27. Immunosuppressive and anticancer effect of a mammalian ribonuclease that targets high-affinity interleukin-2-receptors.
    Yamamura T, Ueda M, Psarras K, Suwa T, Watanaabe Y, Kameyama N, Tanabe M, Imamura H, Kitajima M.
    Eur J Surg; 2002 Jan; 168(1):49-54. PubMed ID: 12022372
    [Abstract] [Full Text] [Related]

  • 28. Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia.
    Ohtsubo H, Arima N, Matsushita K, Hidaka S, Fujiwara H, Arimura K, Kukita T, Fukumori J, Matsumoto T, Eizuru Y, Tanaka H.
    Exp Hematol; 1997 Nov; 25(12):1246-52. PubMed ID: 9357968
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differential roles of Annexin A1 (ANXA1/lipocortin-1/lipomodulin) and thioredoxin binding protein-2 (TBP-2/VDUP1/TXNIP) in glucocorticoid signaling of HTLV-I-transformed T cells.
    Chen Z, Yoshihara E, Son A, Matsuo Y, Masutani H, Sugie K, Maeda M, Yodoi J.
    Immunol Lett; 2010 Jun 15; 131(1):11-8. PubMed ID: 20398702
    [Abstract] [Full Text] [Related]

  • 31. Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2.
    Ahsan MK, Masutani H, Yamaguchi Y, Kim YC, Nosaka K, Matsuoka M, Nishinaka Y, Maeda M, Yodoi J.
    Oncogene; 2006 Apr 06; 25(15):2181-91. PubMed ID: 16314839
    [Abstract] [Full Text] [Related]

  • 32. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
    U-Taniguchi Y, Furuke K, Masutani H, Nakamura H, Yodoi J.
    Oncol Res; 1995 Apr 06; 7(3-4):183-9. PubMed ID: 8555652
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
    Han SB, Park SH, Jeon YJ, Kim YK, Kim HM, Yang KH.
    J Pharmacol Exp Ther; 2001 Nov 06; 299(2):415-25. PubMed ID: 11602650
    [Abstract] [Full Text] [Related]

  • 35. IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines.
    Washiyama M, Nishigaki K, Ahmed N, Kinpara S, Ishii Y, Kanzawa N, Masuda T, Kannagi M.
    FEBS Lett; 2007 Nov 13; 581(27):5207-12. PubMed ID: 17950728
    [Abstract] [Full Text] [Related]

  • 36. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes.
    Pise-Masison CA, Radonovich M, Mahieux R, Chatterjee P, Whiteford C, Duvall J, Guillerm C, Gessain A, Brady JN.
    Cancer Res; 2002 Jun 15; 62(12):3562-71. PubMed ID: 12068005
    [Abstract] [Full Text] [Related]

  • 37. Human leukocyte antigen-class II-negative long-term cultured human T-cell leukemia virus type-I-infected T-cell lines with progressed cytological properties significantly induce superantigen-dependent normal T-cell proliferation.
    Nagasaki M, Zhang J, Morikawa S, Harada T, Nabika T, Tanaka Y.
    Pathol Int; 2005 May 15; 55(5):264-72. PubMed ID: 15871724
    [Abstract] [Full Text] [Related]

  • 38. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines.
    Samaan A, Mahana W.
    Immunol Lett; 2007 Apr 15; 109(2):113-9. PubMed ID: 17368812
    [Abstract] [Full Text] [Related]

  • 39. Functional inactivation of wild-type p53 protein correlates with loss of IL-2 dependence in HTLV-I transformed human T lymphocytes.
    Gartenhaus RB, Wang P.
    Leukemia; 1995 Dec 15; 9(12):2082-6. PubMed ID: 8609720
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.